Congratulations to our country winners!

alt

OpenSound Navigator™ opens up the world

alt

63rd EUHA Congress in Hanover

alt

Predicting how cochlear implant recipients will hear speech

alt

Privacy Regulation and Audiology (II)

Privacy regulation in Europe

Privacy Regulation and Audiology (I)

Privacy regulation in Europe

Get the latest news of the profession: sign up for our newsletter!

Audiology Worldnews newsletter

Interested in Audiology-related events?

Audiology Worldnews agenda

TINNET as the next step in tinnitus research: Towards evidence-based medicine

The Tinnitus Research Initiative (TRI) has come a long way to bring tinnitus research from several scientific fields together. The European funded TINNET, 'Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments', can be regarded as the next step. It aims at coordination and standardization in tinnitus research and the enlargement of an already existing database with results from clinical trials. This should lead to a statistically relevant basis for tinnitus research. It promises the opportunity of standardized processes to enable tailor-made assessment for individual patients.

“At the start of the TRI in 2006 as a private initiative, there was only little tinnitus research compared to the number of people suffering from it. This research was isolated and results remained within the separated domains of ENT, audiology, psychology, psychiatry, and etcetera”, Dr. Berthold Langguth, head of the tinnitus center of Regensburg University concludes. TRI had the vision to bring disciplines together and to share results and insights. “Back then”, Langguth remembers, “the general assumption and conclusion were: 'Tinnitus cannot be cured, so learn to live with it'. The people involved in TRI, however, shared the belief that tinnitus should be treatable in principle – for instance with brain stimulation– although this treatment nor any other treatment was not proven yet. Their motto was and still is: 'Together for a cure'.” Since then, a lot has been achieved. For many patients, the suffering from tinnitus has been reduced.

Evidence base

“But tinnitus still is a very heterogeneous illness. It is difficult to treat”, says Langguth, “treatment is for a large part still mainly pioneering, the domain of pilot studies.” As yet, there are no clearly evidence based treatment methods except cognitive behavioral therapy (CBT) – which comes in several forms. Langguth: “But this doesn't affect the tinnitus percept itself, CBT has the goal to facilitate coping with it. While this provides important relief in many cases, it is not yet the solution for every patient suffering from tinnitus. Apart from that, there are many, many approaches with different rationales. Hearing loss compensation, optionally combined with forms of auditory stimulation, is widely accepted, but large controlled studies demonstrating the efficacy of these approaches are needed. Various innovative forms of individualized auditory stimulation offer sounds or music in frequency areas in the neighborhood of the tinnitus frequency. These forms of individualized auditory stimulation can interact with the neuronal mechanisms that generate tinnitus and have shown promising results in pilot studies.” But there is still a lot unclear, Langguth emphasizes: “How large are the clinical effects? Which variant works best with which type(s) of patients? What can we expect from pharmacological treatment or magnetic and electric brain stimulation? Before these newly developed treatments can be implemented in clinical routine, a conclusive statistical basis from large studies would be needed.”

New knowledge

The TINNET initiative was initiated to change this. It has now been approved by the European Cooperation in Science and Technology (COST) Committee of Senior Officials, thus ensuring European funding. “With that, we get the opportunity to lift tinnitus research to the next level. We still largely depend on the outcomes of isolated trials with a couple of dozens of heterogeneous patients, which causes results to partly depend on group configuration. When data from similar trials from dozens of centers or more can henceforth be introduced in the database, this opens a lot of opportunities.” Once detailed data from many persons is gathered, it will allow us to derive new knowledge, says Langguth: “We could understand in more detail what forms of tinnitus do exist and what the differences between the various forms are. The goal would be to create a data-based expert system, which would provide guidance of which treatment has the best chances for success in a given patient: So hopefully in some years, we can ask the database what would be the recommendation for a 56 years old male, who suffers from a tonal tinnitus since a noise trauma two years ago, and the database would tell us, that a combination of drug X and auditory stimulation Y is the most promising first-line treatment for this individual.”

Dr. Berthold Langguth held a speech on the TINNET initiative during the 8th TRI international Conference from 10-13 March in Auckland, New Zealand. COST invites tinnitus researchers from as many European countries as possible to participate in the project.

Leendert van der Ent


Photo: Lasse Designen - Fotolia
Virtual reality experience to immerse the user in silence
Virtual reality experience to immerse the user in silence

VR

©FatCamera

Australia’s Shepherd Centre, a charity providing a family-centered early intervention program to teach children born deaf or with hearing loss how to develop spoken language, has developed the experience to help people appreciate this condition.

Hearing tests more likely in Germany
Hearing tests more likely in Germany

Eurotrak 2018

©ZdenekSasek

45 % of people questioned in the latest Eurotrak survey in Germany say they have had a hearing test in the last five years, far higher than numbers reported in France and the UK.

"The digital transformation will not replace experts"

Interview

© M. Matos

François Julita, Phonak’s director of digital experience, is responsible for developing digital solutions for responding in better ways to the needs of hearing aid users and hearing care professionals.

Congratulations to the new European AOTY!
Congratulations to the new European AOTY!

AOTY2018

Benjamin Schadow, owner of Hörstil in Erfurt, Germany, has been announced as the 2018 European Audiologist of the Year (AOTY), just weeks after scooping the German Audiologist of the Year title.

AWN EUHA congress special in its 5th year
AWN EUHA congress special in its 5th year

EUHA 2018

Hopefully you are no stranger to our Audiology Worldnews EUHA Congress special print issue as this is the 5th year we provide you with our magazine at the 63rd International Congress of Hearing Aid Audiologists.

Martin Blecker: "At 8,000 delegates, EUHA congress the world's largest convention of its kind"
Martin Blecker:

EUHA 2018

The 63rd EUHA congress will start this Wednesday, October 17, in Hanover. We spoke to Martin Blecker, EUHA president, about the 2018 edition.

Digitization a focus for the German audiology congress
Digitization a focus for the German audiology congress

EUHA 2018

©

From Wednesday 17th October, thousands of audiologists, doctors, students, hearing aid dispensers and industry personnel will descend on Hannover for the 63rd European Union of Hearing Aid Acousticians (EUHA) Congress.

Company Directory

New products

New GSI Allegro launchedNew GSI Allegro launched

Grason-Stadler (GSI) is pleased to announce the release of a new handheld screening tympanometer, the GSI Allegro™.  [ ... ]

Microson will present M4 Open at the EUHA congressMicroson will present M4 Open at the EUHA congress

© Microson

Microson, the only Spanish manufacturer of hearing aids, will attend the EUHA Congress to present their new hearing aid, M4 Open, an innovative open-fit solution. [ ... ]

Hansaton launches beat SHD power hearing systemHansaton launches beat SHD power hearing system

Hansaton presents the beat SHD product family, its most powerful BTE hearing systems with SHD technology for significant hearing loss. [ ... ]